α-LA has been reported to reduce the 24 h urinary albumin excretion and urine albumin/creatinine ratio of patients with DM, and the effect of α-LA alone did not differ from the results of studies in which α-LA was studied in combination with additional medications [156]. Here, ALB is linked to diabetes mellitus.